These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 1290472

  • 1. Renal insensitivity to atrial natriuretic peptide in patients with cirrhosis and ascites. Effect of increasing systemic arterial pressure.
    Ginès P, Titó L, Arroyo V, Llach J, Salmerón JM, Ginès A, Jiménez W, Badalamenti S, Rivera F, Rodés J.
    Gastroenterology; 1992 Jan; 102(1):280-6. PubMed ID: 1290472
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Blunted natriuretic response to low-dose brain natriuretic peptide infusion in nonazotemic cirrhotic patients with ascites and avid sodium retention.
    La Villa G, Riccardi D, Lazzeri C, Casini Raggi V, Dello Sbarba A, Tosti Guerra C, Fronzaroli C, Foschi M, Laffi G, Gentilini P.
    Hepatology; 1995 Dec; 22(6):1745-50. PubMed ID: 7489983
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G, Lazzeri C, Pascale A, Sestini S, Bisi G, Sciagrà R, Vecchiarino S, Raggi VC, Barletta G, Laffi G, Gentilini P.
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [Abstract] [Full Text] [Related]

  • 7. Long-term hypotensive and renal effects of atrial natriuretic peptide.
    Granger JP, Opgenorth TJ, Salazar J, Romero JC, Burnett JC.
    Hypertension; 1986 Jun; 8(6 Pt 2):II112-6. PubMed ID: 2941368
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Long-term administration of isosorbide-5-mononitrate does not impair renal function in cirrhotic patients.
    Salerno F, Borroni G, Lorenzano E, Solenghi D, Cazzaniga M, Bissoli F, Ceriani R, deFranchis R.
    Hepatology; 1996 May; 23(5):1135-40. PubMed ID: 8621145
    [Abstract] [Full Text] [Related]

  • 10. [Renal tubular function in cirrhotic patients with ascites: special reference to lithium clearance following the human atrial natriuretic peptide administration].
    Ando M.
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):791-801. PubMed ID: 1837568
    [Abstract] [Full Text] [Related]

  • 11. Renal nerves mediate blunted natriuresis to atrial natriuretic peptide in cirrhotic rats.
    Koepke JP, Jones S, DiBona GF.
    Am J Physiol; 1987 May; 252(5 Pt 2):R1019-23. PubMed ID: 2953257
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of high dose atrial natriuretic peptide on renal haemodynamics, sodium handling and hormones in cirrhotic patients with and without ascites.
    Jespersen B, Eiskjaer H, Jensen JD, Mogensen CE, Sørensen SS, Pedersen EB.
    Scand J Clin Lab Invest; 1995 Jul; 55(4):273-87. PubMed ID: 7569729
    [Abstract] [Full Text] [Related]

  • 14. Hypotension and renal impairment during infusion of atrial natriuretic factor in liver cirrhosis with ascites.
    Ferrier C, Beretta-Piccoli C, Weidmann P, Gnädinger MP, Shaw S, Suchecka-Rachon K, Saxenhofer H.
    Am J Nephrol; 1989 Jul; 9(4):291-9. PubMed ID: 2530903
    [Abstract] [Full Text] [Related]

  • 15. Effects of auriculin (atrial natriuretic factor) on blood pressure, renal function, and the renin-aldosterone system in dogs.
    Maack T, Marion DN, Camargo MJ, Kleinert HD, Laragh JH, Vaughan ED, Atlas SA.
    Am J Med; 1984 Dec; 77(6):1069-75. PubMed ID: 6239544
    [Abstract] [Full Text] [Related]

  • 16. Role of atrial natriuretic peptide in the natriuretic response to central volume expansion induced by head-out water immersion in sodium-retaining cirrhotic subjects.
    Skorecki KL, Leung WM, Campbell P, Warner LC, Wong PY, Bull S, Logan AG, Blendis LM.
    Am J Med; 1988 Sep; 85(3):375-82. PubMed ID: 2843047
    [Abstract] [Full Text] [Related]

  • 17. Four-hour infusions of synthetic atrial natriuretic peptide in normal volunteers.
    Biollaz J, Nussberger J, Porchet M, Brunner-Ferber F, Otterbein ES, Gomez H, Waeber B, Brunner HR.
    Hypertension; 1986 Jun; 8(6 Pt 2):II96-105. PubMed ID: 2941372
    [Abstract] [Full Text] [Related]

  • 18. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
    Eiskjaer H, Nielsen CB, Pedersen EB.
    J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
    [Abstract] [Full Text] [Related]

  • 19. Natriuretic response to the combination of atrial natriuretic peptide and terlipressin in patients with cirrhosis and refractory ascites.
    Gadano A, Moreau R, Vachiery F, Soupison T, Yang S, Cailmail S, Sogni P, Hadengue A, Durand F, Valla D, Lebrec D.
    J Hepatol; 1997 Jun; 26(6):1229-34. PubMed ID: 9210608
    [Abstract] [Full Text] [Related]

  • 20. Renal actions of atrial natriuretic peptide on the postischemic kidney.
    Akabane S, Imanishi M, Matsushima Y, Kawamura M, Kuramochi M, Ito K, Omae T.
    Can J Physiol Pharmacol; 1988 May; 66(5):601-7. PubMed ID: 2970885
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.